Prostatic Health Status Index.
A prostatic health status index (PHSI) can serve as a quantitative yardstick for decision-making about costs, money, operative indications, operative results, and the efficacy of drug therapy. We have evolved such an index based on the conventional urological work-up by combining the signs and symptoms and the presence or absence of health for determining the economic implications of benign prostatic hypertrophy (BPH). Cost-effectiveness is the analytical tool most commonly used by economists to measure the efficiency of resource utilization for medical care. Essentially, it asks the question, “Is the money being spent for the best results?”
Health Management and Policy
Digital Object Identifier (DOI)
Boyarsky, S. and Woodward, R.S. “Prostatic Health Status Index." Benign Prostatic Hypertrophy. Frank Hinman, Jr. (ed.), New York: Springer Verlag, 1983. pp 766-770. Print.